期刊文献+

HMGB1在Ⅰ型及Ⅱ型子宫内膜癌中的表达及临床意义 被引量:1

The expression and clinical significance of HMGB1 in Type Ⅰ and Type Ⅱ endometrial carcinoma
下载PDF
导出
摘要 目的探究高迁移率族蛋白B1(HMGB1)在Ⅰ型及Ⅱ型子宫内膜癌中的表达及临床意义。方法选取我院2015年1月-2018年12月期间接收的子宫内膜癌患者100例,根据病理分型分为Ⅰ型组(50例)和Ⅱ型组(50例),对比2组HMGB1阳性率。结果Ⅱ型组HMGB1阳性细胞率高于Ⅰ型组,差异有统计学意义(P<0.05)。结论在子宫内膜癌患者中HMGB1表达异常,对其病理分型具有一定的鉴别价值,临床上需要加以重视。 Objective To investigate the expression and clinical significance of high mobility group protein B1(HMGB1)in typeⅠand typeⅡendometrial carcinoma.Methods 100 patients with endometrial cancer received from January 2015 to December 2018 in our hospital were selected.According to the case classification,they were divided intoⅠgroup(50 cases)and typeⅡgroup(50 cases).The expression of HMGB1 was detected by immunohistochemistry in both groups,and the positive rate of HMGB1 was compared between the two groups.Results The incidence of HMGB1 positive cells in typeⅡgroup was higher than that in typeⅠgroup,and the difference was statistically significant(P<0.05).Conclusion There is a certain abnormality in the expression of HMGB1 in the formation of endometrial cancer.Ⅰt has certain application value for the diagnosis of case classification,and it needs to be paid attention to in clinical.
作者 华金仁 曾丹 潘玫 Hua Jinren;Zeng Dan;Pan Mei(The Jiangxi Province Maternal and Child Health Hospital,Nanchang,Jiangxi 330006)
出处 《基层医学论坛》 2020年第4期448-450,共3页 The Medical Forum
基金 江西省卫生计生委科技计划(20175428)
关键词 子宫内膜癌 HMGB1 表达 临床意义 病理分型 Endometrial cancer HMGB Expression Clinical significance Pathological classification
  • 相关文献

参考文献6

二级参考文献26

  • 1冯力元,吴佳捷.小干扰RNA抑制HMGB1表达对子宫内膜癌细胞侵袭与迁移的影响[J].中南大学学报(医学版),2014,39(1):36-42. 被引量:14
  • 2Ferlay J, Soerjomataram I, Ervik M, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012[J]. Int J Cancer, 2015, 136(5): E359-386. 被引量:1
  • 3Tang D, Kang R, Zeh HR, et al. High-mobility group box 1 and cancer[J]. Biochim Biophys Acta, 2010, 1799 ( 1/2): 131-140. 被引量:1
  • 4Shang GH, Jia CQ, Tian H, et al. Serum high mobility group box protein 1 as a clinical marker for non-small cell lung cancer[J]. Respir Med, 2009, 103(12): 1949-1953. 被引量:1
  • 5Ishiguro H, Nakaigawa N, Miyoshi Y, et al. Receptor for advanced glycation end products (RAGE) and its ligand, amphoterin are overexpressed and associated with prostate cancer development[J]. Prostate, 2005, 64(1): 92-100. 被引量:1
  • 6Liu W, Zhang Z, Zhang Y, et al. HMGBl-mediated autophagy modulates sensitivity of colorectal cancer cells to oxaliplatin via MEK/ERK signaling pathway[J]. Cancer Biol Ther, 2015, 16(4): 511-517. 被引量:1
  • 7Wang L, Wang Q, Li HL, et al. Expression of MIR200a, miR93,metastasis-related gene RECK and MMP2/MMP9 in human cervical carcinoma-relationship with prognosis[J]. Asian J Cancer Prev, 2013, 14(3): 2113- 2118. 被引量:1
  • 8Schlueter C, Weber H, Meyer B, et al. Angiogenetic signaling through hypoxia: HMGB 1: an angiogenetic switch molecule[J]. Am J Pathol, 2005, 166(4): 1259-1263. 被引量:1
  • 9Zhu L, Li X, Chen Y, et al. High-mobility group box 1: a novel inducer of the epithelial-mesenchymal transition in colorectal carcinorna[J]. Cancer Lett, 2015, 357(2): 527-534. 被引量:1
  • 10杨国良,薄隽杰.高迁移率族蛋白A2与肿瘤[J].中国癌症杂志,2010,20(2):156-160. 被引量:4

共引文献18

同被引文献6

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部